Patent search ap:("Array BioPharma Inc." OR "GENENTECH Page INC.") AND inv:"James F. Blake"

31.

发明申请
SERINE/THREONINE KINASE INHIBITORS 有权

公开(公告)号：US20160122316A1

公开(公告)日：2016-05-05

申请号：US14993985

申请日：2016-01-12

Applicant: ARRAY BIOPHARMA INC. , GENENTECH, INC.

Inventor： James F. Blake , Mark Joseph Chicarelli , Rustam Ferdinand Garrey , John Gaudino , Jonas Grina , David A. Moreno , Peter J. Mohr , Li Ren , Jacob Schwarz , Huifen Chen , Kirk Robarge , Aihe Zhou

IPC: C07D401/04 , C07D409/14 , C07D413/14 , C07D405/14 , C07D401/14

CPC classification number: C07D401/04 , A61K31/444 , A61K31/506 , A61K31/513 , A61K31/53 , A61K45/06 , C07D401/14 , C07D403/04 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04 , C07F9/65586

Abstract: Compounds of Formula I or a stereoisomer, tautomer, prodrug or pharmaceutically acceptable salt thereof are provided, which are useful for the treatment of hyperproliferative, pain and inflammatory diseases. Methods of using compounds of Formula I or a stereoisomer, tautomer, prodrug or pharmaceutically acceptable salt thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

32.

发明授权
5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors 有权
Title translation: 5H-环戊二烯并[d]嘧啶作为AKT蛋白激酶抑制剂

公开(公告)号：US09328091B2

公开(公告)日：2016-05-03

申请号：US14523481

申请日：2014-10-24

Applicant: Array BioPharma Inc. , Genentech, Inc.

Inventor： Anna Leivers , Josef R. Bencsik , James F. Blake , Martin F. Hentemann , Nicholas C. Kallan , Jun Liang , Ian S. Mitchell , Stephen T. Schlachter , Eli M. Wallace , Rui Xu , Tony P. Tang

IPC: C07D239/70 , C07D401/10 , C07D401/04 , C07D409/04 , C07D417/04 , C07D487/04 , C07D401/12 , C07D403/04 , C07D403/10 , C07D417/10 , C07D211/08 , C07D211/46

CPC classification number: C07D401/10 , C07D211/08 , C07D211/46 , C07D239/70 , C07D401/04 , C07D401/12 , C07D403/04 , C07D403/10 , C07D409/04 , C07D417/04 , C07D417/10 , C07D487/04

Abstract: Compounds of Formula I are useful for inhibiting AKT protein kinases. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

Abstract translation: 式I化合物可用于抑制AKT蛋白激酶。公开了使用式I化合物及其立体异构体及其药学上可接受的盐在体外，原位和体内诊断，预防或治疗哺乳动物细胞或相关病理状况中的这种病症的方法。

33.

发明申请
5H-CYCLOPENTA[d]PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORS 有权
Title translation: 5H-CYCLOPENTA [d]嘧啶酮作为AKT蛋白激酶抑制剂

公开(公告)号：US20150266852A1

公开(公告)日：2015-09-24

申请号：US14523481

申请日：2014-10-24

Applicant: Array BioPharma Inc. , Genentech, Inc.

Inventor： Anna Leivers , Josef R. Bencsik , James F. Blake , Martin F. Hentemann , Nicholas C. Kallan , Jun Liang , Ian S. Mitchell , Stephen T. Schlachter , Eli M. Wallace , Rui Xu , Tony P. Tang

IPC: C07D401/10 , C07D211/08 , C07D211/46

CPC classification number: C07D401/10 , C07D211/08 , C07D211/46 , C07D239/70 , C07D401/04 , C07D401/12 , C07D403/04 , C07D403/10 , C07D409/04 , C07D417/04 , C07D417/10 , C07D487/04

Abstract: Compounds of Formula I are useful for inhibiting AKT protein kinases. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

Abstract translation: 式I化合物可用于抑制AKT蛋白激酶。公开了使用式I化合物及其立体异构体及其药学上可接受的盐在体外，原位和体内诊断，预防或治疗哺乳动物细胞或相关病理状况中的这种病症的方法。

34.

发明申请
HYDROXYLATED PYRIMIDYL CYCLOPENTANE AS AKT PROTEIN KINASE INHIBITOR 审中-公开
Title translation: 羟丙基吡咯烷酮作为AKT蛋白激酶抑制剂

公开(公告)号：US20150051217A1

公开(公告)日：2015-02-19

申请号：US14473336

申请日：2014-08-29

Applicant: Array BioPharma Inc. , Genentech, Inc.

Inventor： Josef R. Bencsik , James F. Blake , Nicholas C. Kallan , Ian S. Mitchell , Keith L. Spencer , Dengming Xiao , Rui Xu , Christine Chabot , Steven Do , Jun Liang , Brian Safina , Birong Zhang , James Graham

IPC: C07D239/70

CPC classification number: C07D239/70

Abstract: The present invention provides a compound and pharmaceutically acceptable salts thereof, comprising the Formula I: Also provided are methods of using the compound of this invention as an AKT protein kinase inhibitor and for the treatment of hyperproliferative diseases such as cancer.

Abstract translation: 本发明提供了包含式I的化合物及其药学上可接受的盐：还提供了使用本发明化合物作为AKT蛋白激酶抑制剂和治疗过度增殖性疾病如癌症的方法。

35.

发明授权
5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors 有权
Title translation: 5H-环戊二烯并[d]嘧啶作为AKT蛋白激酶抑制剂

公开(公告)号：US08895566B2

公开(公告)日：2014-11-25

申请号：US13678395

申请日：2012-11-15

Applicant: Array BioPharma Inc. , Genentech, Inc.

Inventor： Anna Banka , Josef R. Bencsik , James F. Blake , Martin F. Hentemann , Nicholas C. Kallan , Jun Liang , Ian S. Mitchell , Stephen T. Schlachter , Eli M. Wallace , Rui Xu , Tony P. Tang

IPC: A61K31/517 , C07D403/10 , C07D409/04 , C07D239/70 , C07D401/04 , C07D403/04 , C07D487/04 , C07D401/12 , C07D417/10 , C07D401/10 , C07D417/04

CPC classification number: C07D401/10 , C07D211/08 , C07D211/46 , C07D239/70 , C07D401/04 , C07D401/12 , C07D403/04 , C07D403/10 , C07D409/04 , C07D417/04 , C07D417/10 , C07D487/04

Abstract: Compounds of Formula I are useful for inhibiting AKT protein kinases. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

Abstract translation: 式I化合物可用于抑制AKT蛋白激酶。公开了使用式I化合物及其立体异构体及其药学上可接受的盐在体外，原位和体内诊断，预防或治疗哺乳动物细胞或相关病理状况中的这种病症的方法。

36.

发明申请
PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS 有权

公开(公告)号：US20140080829A1

公开(公告)日：2014-03-20

申请号：US14086717

申请日：2013-11-21

Applicant: Genentech, Inc. , Array BioPharma Inc.

Inventor： Josef Bencsik , James F. Blake , James M. Graham , Martin F. Hentemann , Nicholas C. Kallan , Ian S. Mitchell , Stephen T. Schlachter , Keith L. Spencer , Dengming Xiao , Rui Xu , Mike Welch , Jun Liang , Brian S. Safina

IPC: C07D403/12 , C07D403/14 , C07D409/14 , C07D413/12 , C07D401/12 , C07D405/14

CPC classification number: C07D403/12 , C07D401/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/12

Abstract: The present invention provides compounds of Formula I, including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.

37.

发明申请
5H-CYCLOPENTA[D]PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORS 有权
Title translation: 5H-CYCLOPENTA [D]吡啶类作为AKT蛋白激酶抑制剂

公开(公告)号：US20130085135A1

公开(公告)日：2013-04-04

申请号：US13678395

申请日：2012-11-15

Applicant: Array BioPharma Inc. , Genentech, Inc.

Inventor： Anna Banka , Josef R. Bencsik , James F. Blake , Martin F. Hentemann , Nicholas C. Kallan , Jun Liang , Ian S. Mitchell , Stephen T. Schlachter , Eli M. Wallace , Rui Xu , Tony P. Tang

IPC: C07D401/04 , C07D401/10 , C07D403/10 , C07D417/10 , C07D487/04 , C07D401/12 , C07D403/04 , C07D409/04 , C07D239/70

CPC classification number: C07D401/10 , C07D211/08 , C07D211/46 , C07D239/70 , C07D401/04 , C07D401/12 , C07D403/04 , C07D403/10 , C07D409/04 , C07D417/04 , C07D417/10 , C07D487/04

Abstract: Compounds of Formula I are useful for inhibiting AKT protein kinases. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

Abstract translation: 式I化合物可用于抑制AKT蛋白激酶。公开了使用式I化合物及其立体异构体及其药学上可接受的盐在体外，原位和体内诊断，预防或治疗哺乳动物细胞或相关病理状况中的这种病症的方法。